HC Wainwright Reaffirms “Buy” Rating for Beam Therapeutics (NASDAQ:BEAM)
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $80.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 450.21% from the company’s previous close. Several […]
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $80.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 450.21% from the company’s previous close. Several […]